Skip to content
Adam Torkildson – Lifestyle
Author:
Essential Pharma
Essential Pharma appoints Becki Morison as Chief Executive Officer
June 18, 2026
Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma
April 14, 2026